USPTO Publishes Alpha Cognition Patent Application for ZUNVEYL Manufacturing

Alpha Cognition said the USPTO published its U.S. patent application covering a manufacturing process for benzgalantamine, the active ingredient in ZUNVEYL, with impurity-control and scalability features.